Lockheed Martin Q1 2026: The Prime-Execution Drag Shows Up Again

Lockheed Martin’s Q1 print on Thursday was the second defense prime this week to tell investors, plainly, that the problem is not demand — it is conversion. Revenue came in flat at $18.0 billion, GAAP diluted EPS of $6.44 missed the $6.72 LSEG consensus by $0.28, and shares fell about 6.3% on the day. None of it was caused by a weakening book. The backlog hit a record $186.4 billion. What dragged the quarter was F-16 delays tied to flight-test issues on the Taiwan and Morocco production ramp, C-130 transport work held up by supplier availability, and a $325 million step-down in classified Aeronautics volumes.

That combination — record demand, stressed supply chain, engineering rework, margin compression — is, in our view, the same story we laid out in our Northrop Grumman institutional deep dive two days earlier. It is the prime-execution drag thesis, and it is now showing up in print on both of the two largest defense primes in the same week.

What the numbers actually said

The headline miss is real but the mix matters. Missiles and Fire Control sales rose 8% and Space rose 7%, both of which are consistent with the buildout of munitions capacity the Pentagon has been telegraphing for two years. Aeronautics — Lockheed’s biggest segment and the F-35 / F-16 / C-130 hub — slipped 1% on sales and came in at an 8.9% operating margin, meaningfully below the RMS and MFC lines. Rotary and Mission Systems fell 8% on lower radar program volumes and Sikorsky helicopter drag.

The more instructive number is at the bottom of the cash flow statement. Free cash flow came in at negative $291 million for the quarter, a swing of roughly $1.2 billion versus the $955 million Lockheed generated in Q1 2025. Management attributed the gap to working capital timing and billing activity and reaffirmed 2026 full-year free cash flow guidance of $6.5–6.8 billion. In plain English, that means they are telling investors the cash is coming — just not in Q1 — and that the next three quarters need to average north of $2.25 billion each to hit the low end of the range.

The company also did not repurchase a single share in the quarter. Management framed the pause as an alignment with Pentagon priorities around production acceleration; practically, with FCF negative in Q1, there was not much to repurchase against anyway. The $816 million dividend held, and Lockheed retired $1.0 billion of long-term debt.

The demand signal is still very much there

It is worth separating the conversion problem from the book. On the same day the print landed, Lockheed confirmed that Peru had selected the F-16 Block 70 over Gripen and Rafale for a 12-aircraft modernization program valued at roughly $3.4 billion, with production set for the Greenville, South Carolina facility. And Bloomberg reported that the Air Force is preparing to acquire nearly 4,300 JASSM-ER stealth cruise missiles through FY2031, with FY27 buys jumping to 821 units from just 144 in the current fiscal year. That is a roughly 5x step-up in unit demand for the single most stressed munitions line at Missiles and Fire Control, the same segment that already posted 8% sales growth and a 13.7% operating margin.

The setup is striking. A prime with a record backlog, a 5x munitions ramp telegraphed, foreign F-16 orders landing, and the F-35 production profile stepping up to 85 aircraft in FY27 from 47 in FY26 — and the stock down 6.3% on an earnings miss caused by a flight-test issue and a supplier bottleneck. That is what an execution-constrained market looks like.

What we are watching

For readers who cover the defense primes, we think the cross-read across the group is more useful than any single-name conclusion. In our view, three things are worth tracking into the next two quarters:

First, whether the Q2 cash flow bridge materializes the way management described. Working-capital timing explanations are common in long-cycle defense businesses, but they become a credibility issue if the unwind slips a quarter. If Q2 FCF prints below ~$1.5 billion, the 2026 guidance looks noticeably harder.

Second, whether the F-16 flight-test issue and C-130 supplier constraint resolve in a single quarter or bleed into the back half. The classified Aeronautics step-down is a smaller concern because classified lumpiness is well understood; the merchant-facing delays are the ones that matter to investor confidence.

Third, how the MFC margin handles the JASSM ramp. Ramping a missile line from 144 units to 821 units in a single fiscal year is not a margin-accretive event in the short run; it is typically dilutive before it is accretive. The 13.7% MFC operating margin this quarter is a useful reference point. We would not be surprised to see it compress before it expands.

Why this matters for the broader defense trade

The throughline across recent FC defense coverage — the NOC deep dive earlier this week, the Hampton Roads shipbuilding pieces over the last several weeks — is that U.S. defense demand is as strong as any multi-year stretch since the early 2000s, while supply-side execution (engineering talent, suppliers, classified program delivery, working capital intensity) has not caught up. That disconnect is what is showing up in the multiples and the tape.

In our view, Lockheed’s Q1 does not reset the long-term cash generation story for the group — it reinforces that buying defense in 2026 is a bet on management’s ability to convert a historic book into margin, on a timeline the market has already become impatient about. Expect the next two quarters of prints across LMT, NOC, RTX, GD, and HII to be read primarily as conversion updates rather than demand updates.

Forward-looking note: The 2026 guidance, the JASSM ramp cadence, the Peru order conversion, and the Q2 working-capital unwind are forward-looking and reflect our current view. Any or all of them may not materialize as described. Investors should treat the numbers as management and third-party projections rather than commitments.

---

Ferrante Capital LLC is a registered investment adviser. Information presented is for educational purposes only and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. All investing involves risk, including the possible loss of principal.

FC and its principals may hold positions in LMT, NOC. This analysis is for educational purposes only and does not constitute a recommendation to buy, sell, or hold any security.

Forward-looking statements reflect Ferrante Capital’s current analysis and involve assumptions and estimates. Actual results may differ materially. Past performance is not indicative of future results.

Please consult a qualified financial professional before making investment decisions.